<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <title>dagny reese</title>
    <link href="http://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet" type="text/css">
    <link href="styles/style.css" rel="stylesheet" type="text/css">
    <link rel="apple-touch-icon" sizes="180x180" href="images/apple-touch-icon.png">
    <link rel="icon" type="image/png" sizes="32x32" href="images/favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="images/favicon-16x16.png">
    <link rel="manifest" href="/site.webmanifest">
  </head>
  
  <body>
    
  <h1>dagny reese</h1>

    <h2>about</h2>
    
    <p>I am currently a second-year MMSc Immunology Student at HMS and a member of the Garcia-Beltran iNK Lab at the Ragon Institute of Harvard, MIT, and MGH. My work is focused on optimising CAR NK function, chemokines in the tumour microenvironment, and 3D culturing techniques.</p>

    <p>Previously, I completed my BSc in Biomedical Sciences and Drug Mechanisms at UCL. My BSc dissertation project at the <a href="https://www.reevescmvlab.com">Reeve's Lab</a> was on the induction of adaptive-like and tissue resident traits in circulating NK cells in the context of HCMV infection. Prior to that, I was a research assistant at the Biozone Lab for Metabolic Systems Engineering at the University of Toronto's Department of Chemical Engineering. Feel free to email me with any questions about my current or past projects.</p>
      
    <h2>links</h2>
    <ul>
      <li><a href="mailto:dagnyreese@hms.harvard.edu">email</a></li>
      <li><a href="https://twitter.com/dagny416">twitter</a></li>
      <li><a href="https://www.garciabeltranlab.org/">Garcia-Beltran lab website</a></li>
      <li><a href="https://3d.nih.gov/users/dagny416/">my 3D models (NIH 3d Database)</a></li>
    </ul>
      
    <h2>past projects and other work</h2>
    <ul>
      <li>Inducing a Tissue Resident Phenotype in Circulating NK Cells (@ UCL)</li>
      <li>Potential Clinical Usage of Interferon Gamma as An Antiviral Therapy (@ UCL)</li>
      <li>Production of Cis-3-hexen-1-ol in Saccharomyces Cerevisiae (@ Biozone Lab)</li>
    </ul>
      
  </body>
</html>
